Rubius Therapeutics

📍 Cambridge, United States🗓 Founded 2014👥 43 employees💰 Last funded Jan 2018
Biotechnology Research🌐 rubiustx.com
Website LinkedIn
Rubius Therapeutics is a biopharmaceutical company pioneering a new era of cellular medicines. Our proprietary RED PLATFORM™ was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and ready to-use cellular therapies for the potential treatment of several diseases across multiple therapeutic areas. Our initial focus is to advance RCT™ product candidates for the treatment cancer and autoimmune diseases by leveraging two distinct therapeutic modalities — potent cell-cell interaction and tolerance induction. We are currently enrolling patients in a Phase 1/2 clinical trial of RTX-240; the trial has two Phase 1 arms enrolling adult patients with advanced solid tumors: an ongoing monotherapy dose escalation arm in adults with relapsed/refractory or locally advanced solid tumors and a combination therapy dose escalation arm with pembrolizumab in adults with relapsed/refractory or locally advanced solid tumors. In April 2022, the combination arm with pembrolizumab was expanded to focus on non-small cell lung cancer and renal cell carcinoma patients. We are also enrolling patients in a Phase 1/2 clinical trial of RTX-224 for the treatment of patients with certain advanced solid tumors, including non-small cell lung cancer, cutaneous melanoma, head and neck squamous cell carcinoma, urothelial (bladder) carcinoma and triple-negative breast cancer.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Rubius Therapeutics?
Rubius Therapeutics has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Rubius Therapeutics last raise funding?
The most recent investment in Rubius Therapeutics recorded on gritt.io was in January 2018.
When was Rubius Therapeutics founded?
Rubius Therapeutics was founded in 2014.
What industry is Rubius Therapeutics in?
Rubius Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Rubius Therapeutics based?
Rubius Therapeutics is headquartered in Cambridge, United States.